APM Aptorum Group Ltd - Ordinary Shares - Class A
3,836
$4.57
$0.59
(11.43%)
| Watchers | 3,836 |
| 52-Wk Low | $1.35 |
| 52-Wk High | $17.49 |
| Market Cap | $26.74M |
| Volume | 38,695.00 |
| 52-Wk High | $17.49 |
| 52-Wk Low | $1.35 |
Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business UpdateBusiness Wire • 8 days ago
Aptorum Group Limited (Nasdaq: APM) (Aptorum Group or We), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious...
Share to Feed
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Acciones al alza
Aptorum Gr (NASDAQ:APM) experimentaron un repunte del 680,24% para establecerse en los 11,31 d lares durante la sesi n del regular del mi rcoles.
NKGen Biotech (NASDAQ:NKGN...
BeyondSpring, enVVeno Medical, Aptorum Group among healthcare movers...
Aptorum Group Limited (Nasdaq: APM), a clinical stage biopharmaceutical company (Aptorum), and privately-held YOOV Group Holding Ltd. (YOOV) jointly announced today that they entered into an...